Adrian Gottschalk
Patrimonio netto: 2 M $ in data 31/05/2026
Patrimonio netto: 2 M $ in data 31/05/2026
Adrian Gottschalk is President, Chief Executive Officer & Director at Foghorn Therapeutics, Inc. since 2017.
Formerly, Mr. Gottschalk was SVP & Head-Neurodegeneration Therapeutic Area at Biogen, Inc. from 2015 to 2017.
Education includes an undergraduate degree from Texas A&M University in 1997, an MBA from MIT Sloan School of Management in 2003, and a graduate degree from Harvard Medical School in 2004.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 20/04/2026 | 511.704 ( 0,87% ) | 2 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Amministratore Delegato | 01/05/2017 |
| Società | Posizione | Fine |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/05/2017 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Texas A&M University
Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foghorn Therapeutics, Inc.
Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale